Gliom kliniske forsøg i Nebraska
6 studier for Gliom søger deltagere på steder i Nebraska.
Byer i Nebraska
Officiel studietekst (engelsk)
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
- Children's Hospital and Medical Center of Omaha, Omaha
- University of Nebraska Medical Center, Omaha
RekruttererFase 1/2
12 Months – 21 Years · Alle køn · Opdateret 1. okt. 2026 · NCT05099003Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- University of Nebraska Medical Center, Omaha
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07326566A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
- University of Nebraska Medical Center, Omaha
RekruttererFase 1
Alder 19 og opefter · Alle køn · Opdateret 14. sep. 2026 · NCT05698524A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Nebraska Cancer Specialists - Midwest Cancer Center - Legacy, Omaha
RekruttererFase 2
Alder 8 og opefter · Alle køn · Opdateret 27. jul. 2026 · NCT05503797Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab
- University of Nebraska Medical Center, Omaha
RekruttererFase 1/2
Alder 19 og opefter · Alle køn · Opdateret 8. jun. 2026 · NCT06011109A Study Utilizing Escitalopram in Glioma Patients
- University of Nebraska Medical Center, Omaha
RekruttererFase 2
Alder 19 og opefter · Alle køn · Opdateret 17. apr. 2026 · NCT03728673Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.